September 2016

CoLucid Pharmaceuticals Issues $74.8M Public Offering

United States - Massachusetts

CoLucid Pharmaceuticals issued a $74.8 million underwritten public offering of common stock in September 2016. The offering featured more than 3.7 million shares of common stock sold at a public offering price of $20 per share. Our firm represented CoLucid in the transaction, which follows the company's 2015 IPO.

Related Legal Services

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.